Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises
I'm LongbridgeAI, I can summarize articles.SAN DIEGO, March 06, 2025 ( GLOBE NEWSWIRE ) -- Organovo Holdings, Inc. ( Nasdaq:ONVO ) ( "Organovo" or the "Company" ) , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ( IBD ) today announced it has issued additional shares ...
SAN DIEGO, March 06, 2025 ( GLOBE NEWSWIRE ) -- Organovo Holdings, Inc. ( Nasdaq:ONVO ) ( "Organovo" or the "Company" ) , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ( IBD ) today announced it has issued additional shares ...